Please login to the form below

Can patient insights improve clinical trial recruitment strategies?

Clinical trials are a reliable method of testing new treatments before making them available to the general public. To generate the data needed to determine whether the drugs are safe and effective, it’s necessary to conduct double-blind studies with one or more groups of participants. Clinical recruitment strategies are challenging, however, taking the right approach can equip you for success.

Before you can even begin searching for clinical trial participants, you need to get buy-in from a range of stakeholders. By the time sponsors reach the trial stage, most have already invested a great deal in the new product and are likely very confident about its chances of success. Clinical trial marketing and advertising that can effectively get enough participants depends on reaching the right audience, in the right way. That’s where human insights can help improve engagement in clinical trials.

The beauty of patient recruitment strategies

More and more organisations are starting to use data to personalise their marketing processes, especially clinical trial recruitment strategies. By using feedback in combination with wider first-, second- and third-party data and the integration of artificial intelligence (AI), companies are able to enhance their consumers’ satisfaction. With the AI market for healthcare expected to exceed $35 billion by 2020, studies show clinical trials are benefiting from the automation by delivering insights faster (and cheaper) than any human-related processes.

Personalised promotions enable sponsors to effectively target subsets of individuals, whether they are current or future clients. In turn, satisfied people become more willing to give feedback, which triggers a chain effect. By delivering messages that resonate with the audience because of insights gathered, marketers can boost the odds of engaging and converting users by appealing directly to their likes, needs, interests and other preferences. You can only do this if you know what those are, however, which makes the collection of these insights critical for success.

The benefits of patient insights

Sponsors can get valuable insights by identifying what their consumers say they are doing and what they actually are doing. These enable marketers to not only personalise clinical trial marketing and advertising, but to identify the factors that drive them to choose one treatment or provider over another. This can be pivotal in clinical trial recruitment strategies, because it generates a level of trust between the participant and the research site.

Human insights are incredibly valuable for building competitive advantage, too. In this world of stiff competition between sponsors, study teams need all the advantages they can get to help them stay ahead. Gathering insights from consumers who are potential trial participants can help you tailor both the trial design as well as your clinical trial recruitment strategies to the right audience. With a clearer understanding of what works and what doesn’t, the clinical trial marketing and advertising materials will be stronger and will achieve better results for your clinical trial recruitment strategies.

The one activity that will have a profound effect on clinical trial marketing and advertising over the next decade will be the digitisation of people’s medical information. This will enable the various medical and related industries, including pharma, to use real-world data in powerful ways. At present, randomised clinical trials compare new treatments with former or standard methods, which means most trials need to increase the number of enrolments to have a control arm. Identifying eligible participants for both active and control arms adds a large amount of time and cost to the process, but the availability of electronic medical history and former trial participation will significantly reduce this.

The development of patient trust

According to The Patient Gap, a report developed from the analysis of three proprietary studies, 6% of healthcare clients hold the belief that biopharma companies are on their side. Most are convinced the companies are developing treatments for commercial gain, above all other reasons. This causes a high level of distrust, which makes engaging with them challenging and getting them to join a clinical trial almost impossible.

Even when a campaign is backed by a large clinical trial marketing and advertising budget, it means little to healthcare if it isn’t able to attract the numbers needed for the trial. Since different consumers will have very different reasons for joining a trial, they need to be able to clearly see that your brand understands their challenges and takes note of these throughout the interactions with them.

Building patient insights into your clinical trial recruitment strategies

It’s important to view the insights you gather through the lens of their impact on participants’ lives. Some questions to help you determine the best way to use the data are:

  • What is the ideal prospect’s level of knowledge about the disease or condition before taking part in the study and do you need to provide education to encourage them to join?
  • How long will the study last and how will participation and/or site visits impact peoples’ lives?
  • How far away are the research sites and how often will participants need to physically attend?

These are some of the important factors in a health seeker’s journey, so they need to be the basis of your creative clinical trial recruitment strategies.

Identifying the answers to these questions enables you to address them as potential objections in your approach. This reassures the prospect that their issues have been considered and the company conducting the trials cares about them.

This blog was first published here:

29th April 2020



Company Details

COUCH Health

+44 (0) 330 995 0656

Contact Website

Suite 2.10, Jactin House
24 Hood Street
M4 6WX
United Kingdom

Latest content on this profile

What you can do to help make invisible illnesses more visible?
Before we begin, you might be wondering what exactly an invisible illness is. An invisible illness is an umbrella term for any medical condition that isn't easily visible to others. This can include chronic physical conditions like arthritis and diabetes, or mental illnesses.
COUCH Health
Training for PI's and study staff has to change now
We need to make sure sites receive training that truly focuses on meeting needs.
COUCH Health
#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial release, “The Reporting of Race and Ethnicity in Medical and Science Journals”. Substantial changes have been made in the race/ethnicity data section. But what does this mean?
COUCH Health
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?
COUCH Health
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities in representation in COVID-19 clinical trials?
COUCH Health
Abbie's (associate copywriter) first 6-months at COUCH Health
Like many others. Abbie spent the majority of her time over the last few months indoors. Yet, the last 6 months have gone very quickly. This is mainly due to the fact that, somehow, she managed to land herself a pretty good job during the height of a global pandemic.
COUCH Health